Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 2 of 15
Reducing Obesity Using Social Ties Program
NCT06335810
Effect of an Educational Nail Biopsy Video on Pre-operative Anxiety, Health Literacy, and Patient Satisfaction
NCT06274775
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
NCT06300463
Optimizing Surgical Decisions in Young Adults With Breast Cancer
NCT06275126
STICH3C Cardiac Magnetic Resonance Observational Study
NCT07133984
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
NCT05948657
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
NCT06072807
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
NCT06168604
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
NCT05743621
Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
NCT05994235
Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
NCT04887116
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
NCT05934838
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
NCT06039930
Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals
NCT05897619
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
NCT05925322
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
NCT05583708
Mobile CBT for Middle Aged and Older Adults
NCT05754151
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
NCT05618366
Transcranial Direct Current Stimulation for Post-stroke Fatigue
NCT05816603
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
NCT05943210
Clinical Trial of Approaches to Prostate Cancer Surgery
NCT05155501
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120
Double Voiding and Post-transplant UTI
NCT05711446
Mind-Body Skills Group for Graduate Students
NCT05447689
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
NCT05507138
Habit Awareness Device for Treatment of Onychophagia
NCT06111729
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
NCT05562778
Beta-blocker Administration for Cardiomyocyte Division
NCT04713657
Engage & Connect: A Psychotherapy for Postpartum Depression
NCT05585164
Pain Reduction Using NEurostimulation Study
NCT05311956
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
NCT05587517
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
NCT05081596
Investigation of Surgical Sectioning of the Filum Terminale in Treating Occult Tethered Cord Syndrome Patients
NCT05163899
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT05332613
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
NCT05183230
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
NCT05024097
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
NCT05302271
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
NCT06094257
General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19
NCT04626050
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
NCT05134779
Accelerated TMS for Depression and OCD
NCT04982757
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
NCT04679012
Biomarker-guided rTMS for Treatment Resistant Depression
NCT04041479
FaCT Trial (Facilitated Cascade Testing Trial)
NCT04613440
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
NCT05164744
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
NCT04886986
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
NCT04891510
Chronic Pain Diagnosis and Treatment in Torture Survivors
NCT04629963
Parkinson's Disease Biomarkers in Nerve Cells in the Gut
NCT05347407
Combined Immunotherapies in Metastatic ER+ Breast Cancer
NCT04563507
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets.Report a data error.